Recent Developments in Diffuse Large B-Cell Lymphoma

(MedPage Today) -- Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug conjugate in relapsed/refractory disease, FDA issues with a randomized trial, and an increased risk of...